Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Clinical and Vaccine Immunology : CVI
|
August 5, 2011
Comparison of a new multiplex binding assay versus the enzyme-linked immunosorbent assay for measurement of serotype-specific pneumococcal capsular polysaccharide IgG
David Goldblatt, Lindsey Ashton, Yuhua Zhang, et al.
Journal of Immunoassay & Immunochemistry
|
September 30, 2008
Complexities of clinical assay development and optimization prior to first-in-man immunization trials - a description of immunogenicity assay development for the testing of samples from a phase 1 Alzheimer's vaccine trial
Olivia Hammond, James Reynolds, Leonard J Rubinstein, et al.
Pediatric Transplantation
|
February 12, 2009
Sustainability of humoral responses to varicella vaccine in pediatric transplant recipients following a pretransplantation immunization strategy
Michelle Barton, Samia Wasfy, Toni Melbourne, et al.
Vaccine
|
January 18, 2003
Memory T cells and vaccines
Mark T Esser, Rocio D Marchese, Lisa S Kierstead, et al.
Clinical and Vaccine Immunology : CVI
|
January 23, 2009
Optimization and validation of a multiplex, electrochemiluminescence-based detection assay for the quantitation of immunoglobulin G serotype-specific antipneumococcal antibodies in human serum
Rocio D Marchese, Derek Puchalski, Pamela Miller, et al.
Journal of Medical Virology
|
October 26, 2006
The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection
Olivia Hammond, Yue Wang, Tina Green, et al.
Human Vaccines
|
August 24, 2011
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults
Daniel M Musher, Susan B Manoff, Richard D McFetridge, et al.
The Journal of Infectious Diseases
|
January 23, 2010
Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults
Daniel M Musher, Susan B Manof, Charlie Liss, et al.
Clinical and Vaccine Immunology : CVI
|
August 9, 2006
Enzyme-linked immunosorbent assay for measuring antibodies to pneumococcal polysaccharides for the PNEUMOVAX 23 vaccine: assay operating characteristics and correlation to the WHO international assay
Rocio D Marchese, Neil T Jain, Joseph Antonello, et al.
Vaccine
|
March 22, 2018
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of age
Susan J Ermlich, Charles P Andrews, Steven Folkerth, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Clinical and Vaccine Immunology : CVI
|
August 5, 2011
Comparison of a new multiplex binding assay versus the enzyme-linked immunosorbent assay for measurement of serotype-specific pneumococcal capsular polysaccharide IgG
David Goldblatt, Lindsey Ashton, Yuhua Zhang, et al.
Journal of Immunoassay & Immunochemistry
|
September 30, 2008
Complexities of clinical assay development and optimization prior to first-in-man immunization trials - a description of immunogenicity assay development for the testing of samples from a phase 1 Alzheimer's vaccine trial
Olivia Hammond, James Reynolds, Leonard J Rubinstein, et al.
Pediatric Transplantation
|
February 12, 2009
Sustainability of humoral responses to varicella vaccine in pediatric transplant recipients following a pretransplantation immunization strategy
Michelle Barton, Samia Wasfy, Toni Melbourne, et al.
Vaccine
|
January 18, 2003
Memory T cells and vaccines
Mark T Esser, Rocio D Marchese, Lisa S Kierstead, et al.
Clinical and Vaccine Immunology : CVI
|
January 23, 2009
Optimization and validation of a multiplex, electrochemiluminescence-based detection assay for the quantitation of immunoglobulin G serotype-specific antipneumococcal antibodies in human serum
Rocio D Marchese, Derek Puchalski, Pamela Miller, et al.
Journal of Medical Virology
|
October 26, 2006
The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection
Olivia Hammond, Yue Wang, Tina Green, et al.
Human Vaccines
|
August 24, 2011
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults
Daniel M Musher, Susan B Manoff, Richard D McFetridge, et al.
The Journal of Infectious Diseases
|
January 23, 2010
Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults
Daniel M Musher, Susan B Manof, Charlie Liss, et al.
Clinical and Vaccine Immunology : CVI
|
August 9, 2006
Enzyme-linked immunosorbent assay for measuring antibodies to pneumococcal polysaccharides for the PNEUMOVAX 23 vaccine: assay operating characteristics and correlation to the WHO international assay
Rocio D Marchese, Neil T Jain, Joseph Antonello, et al.
Vaccine
|
March 22, 2018
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of age
Susan J Ermlich, Charles P Andrews, Steven Folkerth, et al.
Page
of 2